i-Base home
Search Menu
  • Home
  • HTB
  • 2006
  • June
  • 10

HTB

10 June 2006

Contents

Conference reports

  • Effects of ketoconazole and rifampin on TMC278
  • Brecanavir interaction study with ritonavir and atazanavir
  • Fixed-dose formulation of efavirenz/tenofovir/FTC bioequivalent to separate dosing
  • Saquinavir/r (1000/100mg) levels reduced when taken fasted and should be taken with food
  • Lack of food effect with Meltrex formulation of lopinavir/r
  • Food interaction reduces ddI intracellular absorption and supports requirement to take fasted
  • Conflicting results on how T-20 affects tipranavir

Treatment strategies

  • Autologous stem cells transplant (ASCT) in HIV-positive individuals with a relapsed non-Hodgkin’s lymphoma (NHL) or Hodgkin’s disease (HD)

Treatment access

  • ITPC publish updated report on access to treatment
  • Protesters evicted from UN headquarters, New York
  • Community opposition filed against tenofovir patent application in India

Guidelines

  • US adult treatment guidelines updated (May 2006)
  • Draft BHIVA immunisation guidelines online (2006)

TB coinfection

  • HIV linked to lower rifampin and ethambutol AUCs in TB cohort

Resistance

  • Web resources for HIV-1 genotypic-resistance test interpretation

Other news

  • LGV in the UK: almost 350 cases reported and still predominantly affecting HIV-positive gay men

On the web

  • Conference abstracts and reports
  • HIV InSite: new chapters
  • PLoS Medicine articles
  • New HIV vaccine website
  • HTB RSS

Current issues

  • August 2022
  • July 2022
  • June 2022
  • Back issues

Special report

  • Taking a break from monkeypox: four weeks out for August 3 August 2022

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook